Jun 10, 2021 04:22 PM IST
By the end of June, global vaccine alliance staring at a shortfall of 190 million doses.
- Jun 02, 2021 09:48 AM IST
The Bombay High Court said Maharashtra's top officials must personally speak to Serum Institute of India (SII) CEO Adar Poonawalla, who recently went to London, and assure him of his safety upon his return to India.
- May 31, 2021 05:14 PM IST
Deshwal is currently a business head at ICICI Bank, responsible for its fast-growing services sector, including new age businesses. He is also responsible for driving the liability strategy for the corporate ecosystem at the bank.
- May 23, 2021 03:41 PM IST
Amid an acute shortage of COVID-19 vaccines in the country, SII executive director Suresh Jadhav on Friday alleged that the government began inoculating people from multiple age groups without taking into account the available stock of vaccines and the WHO guidelines.
- May 17, 2021 09:48 PM IST
The shares were picked by Serum Institute of India (SII). As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share, taking the total deal value to Rs 118.02 crore.
- May 04, 2021 09:38 AM IST
The announcement comes a couple of hours ahead of a virtual bilateral summit between Prime Minister Narendra Modi and his British counterpart Boris Johnson. SII is already running phase 1 trials of its new one dose nasal vaccine in the UK, which may be produced in the country once approved.
- May 03, 2021 02:11 PM IST
The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."
- May 02, 2021 08:32 AM IST
Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.
- May 01, 2021 07:32 PM IST
Serum Institute of India boss Adar Poonawalla in interview to London Times reveals why he is in the UK and talks about the pressure to deliver vaccines in India.
- Apr 28, 2021 08:01 PM IST
Poonawalla, 40, is one of the key players in the country's fight against the COVID-19 pandemic.
- Apr 28, 2021 05:33 PM IST
The vaccine manufactured by Serum Institute of India was earlier priced at Rs 400 per dose for the state governments.
- Apr 26, 2021 02:43 PM IST
In November 2020, Wellness Forever had raised Rs 130 crore from HNIs led by Adar Poonawalla.
- Apr 22, 2021 05:53 PM IST
Gorakhpur MLA Radha Mohan Das Agrawal made the remarks after SII on Wednesday announced a price of Rs 600 per dose for Covishield supplies to private hospitals and Rs 400 per dose to state governments.
- Apr 21, 2021 05:36 PM IST
SII will never take advantage of the pandemic, we are losing Rs 150 per dose now, says Poonawalla.
- Apr 20, 2021 02:00 PM IST
Adar Poonawalla's tweet came a day after the Centre approved an advance of around Rs 3,000 crore to the Serum Institute of India. Poonawalla had earlier said that the amount would be needed to ramp up production capacity.
- Apr 16, 2021 04:17 PM IST
The difference of opinion has especially widened on whether the dire situation at hand requires the government to provide direct funding to the largest vaccine maker in the world.
- Apr 07, 2021 08:24 AM IST
The company is a key supplier for the U.N.-backed COVAX program that aims to distribute vaccines equitably in the world. On March 25, COVAX announced a major setback in its vaccine rollout because a surge in infections in India caused the Serum Institute of India to cater to domestic demand, resulting in a delay in global shipments of up to 90 million doses.
- Apr 06, 2021 06:36 PM IST
Adar Poonawalla said that the Serum Institute of India has already delivered over 100 million doses to the government and is currently producing 65-70 million doses per month.
- Mar 27, 2021 02:29 PM IST
In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.
- Mar 25, 2021 10:30 AM IST
The CEO of Serum Institute of India has reportedly leased a 25,000 square feet property in London's Mayfair from Polish billionaire Dominika Kulczyk.
- Mar 18, 2021 10:15 PM IST
The second batch of five million doses that SII is due to export to the UK will only be delivered once it is green-lighted by the Indian government.
- Mar 17, 2021 08:59 AM IST
Countries are holding on to their supplies and restricting access to material required to manufacture more doses of vaccines against COVID-19, Poonawalla
- Mar 12, 2021 03:38 PM IST
In 2015, Svasti had raised funds from billionaire Adar Poonawalla, who subsequently invested in all follow-on rounds and now in the current round as well.
- Feb 15, 2021 06:44 PM IST
Prior to COVID-19 pandemic, India had been producing 60 percent of the world's vaccines for various diseases at an affordable rate.
- Feb 12, 2021 04:19 PM IST
In this advertisement, a man is seen proposing to his girlfriend with a dose of the vaccine instead of a ring. "Inoculate yourself... with love," the ad suggests before concluding with a shot of the Pfizer vaccine which is "not available anywhere".